Overview
Status
Active
Registry date
2019-05-15
Share capital
9,000.00 PLN
Registered address
ul. Belwederska 9/1, 00-761 Warszawa, Poland
Industry
Authorized Representatives
Agnieszka Małgorzata Dąbrowskaage 42 – President of the Management Board
Manner of representation
To make declarations of will on behalf of the company, in the case of a one-person management board, a member of the management board is authorised to act independently, whereas in the case of a multi-member management board, the President of the Management Board is authorised to act independently or two members of the management board acting jointly are authorised.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 60 | $1,620.75 | 66.6667% | |
Hanna Elżbieta Dąbrowskaage 62 | 30 | $810.37 | 33.3333% |
Agnieszka Małgorzata Dąbrowska and Hanna Elżbieta Dąbrowska hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Roche Polskasp. z o.o. | $799,694,562.77 | roche.pl | ||
| USP Zdrowiesp. z o.o. | $377,149,656.94 | uspzdrowie.pl | ||
| Bialmedsp. z o.o. | $203,238,055.12 | bialmed.pl | ||
| Orkla CareS.A. | $43,777,691.06 | orklacare.com.pl | ||
| Hair Partnerssp. z o.o. | $4,347,484.74 | hairpartners.pl | ||
| Balmed Polandsp. z o.o. | $3,140,735.80 | balmed.it | ||
| Beauty Care Solutionsp. z o.o. | $391,209.94 | ohhira.pl | ||
| Vorwarts Pharmasp. z o.o. | $210,138.62 | vorwartspharma.pl | ||
| Black & Whitesp. z o.o. | $154,866.36 | polonus.pl | ||
| Biodermaticsp. j. | – | biodermatic.com |
FAQ
The main business activity of Neuracor focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on May 15, 2019.
The headquarters is located at: ul. Belwederska 9, 00-761 Warszawa.
The share capital of the company is PLN 9,000 (approx. $2,431).
The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.
Last updated: 2026-04-13